Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLIPUDASE ALFA-RPCP: 96 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
96
Total FAERS Reports
1 (1.0%)
Deaths Reported
13
Hospitalizations
96
As Primary/Secondary Suspect
Prescription
Status

FDA Application: 761261 ·

First Report: 20220101 · Latest Report: 20250509

What Are the Most Common OLIPUDASE ALFA-RPCP Side Effects?

#1 Most Reported
Incorrect dose administered
10 reports (10.4%)
#2 Most Reported
Headache
8 reports (8.3%)
#3 Most Reported
Fatigue
7 reports (7.3%)

All OLIPUDASE ALFA-RPCP Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Incorrect dose administered 10 10.4% 1 2
Headache 8 8.3% 0 1
Fatigue 7 7.3% 0 0
Erythema 5 5.2% 0 1
Pyrexia 5 5.2% 1 3
Sinusitis 5 5.2% 0 0
Weight increased 5 5.2% 0 0

Who Reports OLIPUDASE ALFA-RPCP Side Effects? Age & Gender Data

Gender: 71.0% female, 29.0% male. Average age: 12.9 years. Most reports from: US. View detailed demographics →

Is OLIPUDASE ALFA-RPCP Getting Safer? Reports by Year

YearReportsDeathsHosp.
2022 8 0 2
2023 23 1 5
2024 17 0 4
2025 8 0 1

View full timeline →

What Is OLIPUDASE ALFA-RPCP Used For?

IndicationReports
Niemann-pick disease 80

Official FDA Label for OLIPUDASE ALFA-RPCP

Official prescribing information from the FDA-approved drug label.